API INTERMEDIATES

INTERMEDIATES

S.NoAPI NameCASNOIntermediate for APITHERPAUTIC CATEGORYQUOTE
1.1SITAGLIPTIN762240-92-63-(Trifluoromethyl)-5,6,7,8-Tetrahydro-[1,2,4]Triazolo[4,3-A]Pyrazine HydrochlorideANTI-DIABETIC
1.2SITAGLIPTIN764667-65-4Sitagliptin Keto Amide Impurity//1-(3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butane-1,3-dione.ANTI-DIABETIC
1.3SITAGLIPTIN767340-03-4Sitagliptin Enamine ImpurityANTI-DIABETIC
1.4SITAGLIPTIN832817-56-7Sitagliptin Impurity E/ Racemic SitagliptinANTI-DIABETIC
1.5SITAGLIPTIN769195-26-8Methly 3-Oxo-4-(2,4,5-Trifluorophenly)Butanoate ANTI-DIABETIC
1.6SITAGLIPTIN881995-70-6(Z)-Methyl 3-Amino-4-(2,4,5-Trifluorophenyl)But-2-EnoateANTI-DIABETIC
1.7SITAGLIPTIN1234321-81-3(Z)Methyl 3-Acetomido-4-(2,4,5-Trifluorophenyl)But-2-EnoateANTI-DIABETIC
1.8SITAGLIPTIN1234321-83-5Sitagliptin Impurity /Methyl®-3-Acetamido-4-(2,4,5-Trifluorophenyl)ButanoateANTI-DIABETIC
2.1EMPAGLIFLOZIN86087-23-2(S)-(+)-3-HydroxytetrahydrofuranANTI-DIABETIC
2.2EMPAGLIFLOZIN915095-85-1(5-Bromo-2-Chlorophenyl)(4-Fluorophenyl)MethanoneANTI-DIABETIC
2.3EMPAGLIFLOZIN915095-89-5(3S)-3-{4-[(5-Bromo-2-Chlorophenyl)Methyl]Phenoxy}OxolaneANTI-DIABETIC
2.4EMPAGLIFLOZIN915095-99-7(2R,3R,4R,5S,6S)-3,4,5-Tris(Acetyloxy)-6-[4-Chloro-3-({4-[(3S)-Oxolan-3-Yloxy]Phenyl}Methyl)Phenyl]Oxan-2-Yl]Methyl AcetateANTI-DIABETIC
2.5EMPAGLIFLOZIN333361-51-64-(5-Bromo-2-Chlorobenzyl)Phenyl Methyl EtherANTI-DIABETIC
2.6EMPAGLIFLOZIN32384-65-92,3,4,6-Tetra-O-Trimethylsilyl-Beta-D-GlucolactoneANTI-DIABETIC
2.7EMPAGLIFLOZIN915095-84-0(5-Bromo-2-Chlorophenyl)[4-[[(3S)-Tetrahydro-3-Furanyl]Oxy]Phenyl]Methyl]MethanoneANTI-DIABETIC
2.8EMPAGLIFLOZIN915095-94-2(3S)-3-[4-[(2-Chloro-5-Iodophenyl)Methyl]Phenoxy]Tetrahydro-FuranANTI-DIABETIC
2.9EMPAGLIFLOZIN714269-57-5Methyl 1-C-[4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl]-Alpha-D-GlucopyranosideANTI-DIABETIC
2.10EMPAGLIFLOZIN864070-18-84-(5-Bromo-2-Chlorobenzyl)PhenolANTI-DIABETIC
2.11EMPAGLIFLOZIN1103738-29-91-Chloro-2-[(4-Ethoxyphenly)Methyl]-4-IodobenzeneANTI-DIABETIC
3.1DAPAGLIFLOZIN461432-22-4(5-Bromo-2-Chlorophenyl)(4-Ethoxyphenyl)MethanoneANTI-DIABETIC
3.2DAPAGLIFLOZIN461432-23-51-(5-Bromo-2-Chlorobenzyl)-4-Ethoxybenzene/5-Bromo-2-Chloro-4’-EthoxydiphenylmethaneANTI-DIABETIC
3.3DAPAGLIFLOZIN461432-24-6(2S,3R,4S,5S,6R)-2-{4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl}-6-(Hydroxymethyl)-2-Methoxyoxane-3,4,5-TriolANTI-DIABETIC
3.4DAPAGLIFLOZIN461432-25-7[(2R,3R,4R,5S,6S)‐3,4,5‐Tris (Acetyloxy) ‐6‐{4‐Chloro‐3‐[(4‐Ethoxyphenyl) Methyl] Phenyl}Oxan‐2‐Yl]Methyl Acetate//(1S)-1,5-Anhydro-1-C-[4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl]-D-Glucitol TetraacetateANTI-DIABETIC
3.5DAPAGLIFLOZIN333359-90-3(2S,3R,4R,5S,6R)-2-{4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl}-6-(Hydroxymethyl) Oxane-3,4,5-TriolANTI-DIABETIC
3.6DAPAGLIFLOZIN333361-51-64-Bromo-1-Chloro-2-(4-Methoxybenzyl)BenzeneANTI-DIABETIC
3.7DAPAGLIFLOZIN714269-57-5Methyl 1-C-[4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl]-Alpha-D-Glucopyranoside ANTI-DIABETIC
3.8DAPAGLIFLOZIN32384-65-92,3,4,6-Tetrakis-O-Trimethylsilyl-D-GluconolactoneANTI-DIABETIC
3.9DAPAGLIFLOZIN333361-49-2(5-Bromo-2-Chlorophenyl)(4-Methoxyphenyl)-MethanoneANTI-DIABETIC
3.10DAPAGLIFLOZIN1360568-68-8(5-Bromo-2-Chlorophenyl)(4-Hydroxyphenyl)MethanoneANTI-DIABETIC
3.11DAPAGLIFLOZIN864070-18-84-(5-Bromo-2-Chlorobenzyl)PhenolANTI-DIABETIC
3.12DAPAGLIFLOZIN1103738-29-91-Chloro-2-[(4-Ethoxyphenyl)Methyl]-4-IodobenzeneANTI-DIABETIC
4.1APIXABAN1267610-26-31-(4-Amino Phenyl)-5,6-Dihydro-3-Morpholino-Pyridin-2(1H)-OneANTI-COAGULANT
4.2APIXABAN545445-44-15,6-Dihydro-3-Morpholino-1-(4-(2-Oxo Piperidin-1-Yl) Phenyl)Pyridin)2(1H) OneANTI-COAGULANT
4.3APIXABAN27143-07-3(Z)-Ethyl-2-Chloro-2-(2-(4-Methoxy Phenyl) Hydrazono Acetate/Ethyl Chloro[(4-Methoxyphenyl)Hydrazono]AcetateANTI-COAGULANT
4.4APIXABAN536759-91-8Ethyl 4,5,6,7-Tetrahydro-1-(4-Methoxyphenyl)-6-(4-Nitrophenyl)-7-Oxo-1H-Pyrazolo[3,4-C]Pyridine-3-Carboxylate//4,5,6,7-Tetrahydro-1-(4-Methoxyphenyl)-6-(4-Nitrophenyl)-7-Oxo-1H-Pyrazolo[3,4-C]Pyridine-3-Carboxylic Acid Ethyl EsterANTI-COAGULANT
4.5APIXABAN881386-12-5Ethyl 6-(4-(5-Bromopentanamido) Phenyl)-4,5,6,7-Tetrahydro-1-(4-Methoxyphenyl)-7-Oxo-1H-Pyrazolo[3,4,-C]Pyridine-3-CarboxylateANTI-COAGULANT
4.6APIXABAN503614-91-3Ethyl 1-(4-Methoxyphenyl)-7-Oxo-6-[4-(2-Oxopiperidin-1-Yl)Phenyl]-4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine-3-CarboxylateANTI-COAGULANT
4.7APIXABAN503614-92-41-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxopiperidin-1-Yl)Phenyl)-4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine-3-Carboxylic AcidANTI-COAGULANT
5.1RIVAROXABAN438056-69-0[4-(4-Aminophenyl)Moropholin-3-One] (KSM)ANTI-THROMBOTIC
5.2RIVAROXABAN161596-47-0([2-[(2S)-Oxiran-2-Ylmethyl]-1H-Isoindole-1,3(2H)-Dione (KSM)ANTI-THROMBOTIC
5.3RIVAROXABAN24065-33-65-Chlorothiophene-2-Carboxyilic Acid (KSM)ANTI-THROMBOTIC
5.4RIVAROXABAN446292-07-52-[(2R)-2-Hydroxy-3-{[4-(3-Oxomorpholin -4-Yl) Phenyl]Amino}Propyl]-1H-Isoindole-1,3(2H)-DioneANTI-THROMBOTIC
5.5RIVAROXABAN446292-08-62-({(5S)-2-Oxo-3-[4-(3-Oxomorpholin-4-Yl)Phenyl]-1,3-Oxazolidin-5-Yl}Methyl)-1H-Isoindole-1,3(2H)-DioneANTI-THROMBOTIC
5.6RIVAROXABAN898543-06-14-{4-[(5S)-5-(Aminomethyl)-2-Oxo-1,3-Oxazolidin-3-Yl]Phenyl}Morpholin-3-One Hydrochloride.ANTI-THROMBOTIC
6.1DABIGATRAN103041-38-9Ethyl-3-(Pyridin-2Yl-Amino) Propionate.ANTI-THROMBOTIC
6.2DABIGATRAN42288-26-64-Cyano Phenyl Glycine.ANTI-THROMBOTIC
6.3DABIGATRAN212322-56-03-[(3-A-4-Mab Pyridine-2-Ylamino]Propionicacid Ethyl EsterANTI-THROMBOTIC
6.4DABIGATRAN873-74-54-Amino Benzonitrile.ANTI-THROMBOTIC
6.5DABIGATRAN1307233-94-8Ethyl-3-(2-Chloro Methyl)-1-Methyl-N-(Pyridin-2Yl)-1H-Benzo (D)-Imidazole-5-Carboxamido PropanoateANTI-THROMBOTIC
6.6DABIGATRAN277319-62-74-Amino-N-Hydroxy BenzimidamideANTI-THROMBOTIC
6.7DABIGATRAN1307233-93-7Hexyl Amino-4-Amino Phenyl Methylene CarbamateANTI-THROMBOTIC
6.8DABIGATRAN211915-06-9Dabigatran EtexilateANTI-THROMBOTIC
6.9DABIGATRAN872728-81-9Dabigatran Etexilate MesylateANTI-THROMBOTIC
6.10DABIGATRAN211915-84-3Ethyl 3-(2-(((4-Cyanophenyl) Amino)Methyl)-1-Methyl-N-(Pyridin-2-Yl)-1H-Benzo [D]Imidazole-5-Carboxamido)PropanoateANTI-THROMBOTIC
6.11DABIGATRAN211915-06-9Ethyl 3-[[[2-[[[4-[[[(Hexyloxy)Carbonyl]Amino]Iminomethyl]Phenyl] Amino]Methyl]-1-Methyl-1H-Benzimidazol-5-Yl]Carbonyl](Pyridine-2-Yl)Amino]PropanoateANTI-THROMBOTIC
6.12DABIGATRAN1229006-21-6Methyl 5-(2,4-Difluorobenzylcarbamoyl) -3-(Benzyloxy)-1,4-Dihydro-1-(2,2-Dimethoxyethyl)-4-Oxopyridine-2-Carboxylate.ANTI-THROMBOTIC
6.13DABIGATRAN1206102-11-5(4R,12As)-N-(2,4-Difluorobenzyl)-7-Benzyloxy-4-Methyl-6,8-Dioxo-3,4,6,8,12,12A-Hexahydro-2H-Pyrido[1',2':4,5]Pyrazino[2,1-B][1,3]Oxazine-9-CarboxamideANTI-THROMBOTIC
6.14DABIGATRAN1051375-16-6(4R,12As)-N-(2,4-Difluorobenzyl)-7-Hydroxy-4-Methyl-6,8-Dioxo-3,4,6,8,12,12A-Hexahydro-2H-Pyrido[1',2':4,5]Pyrazino[2,1-B][1,3]Oxazine-9-CarboxamideANTI-THROMBOTIC
6.15DABIGATRAN1246616-66-9Dimethyl 3-(Benzyloxy)-4-Oxo-4H-Pyran-2,5-DicarboxylateANTI-THROMBOTIC
7.1CELECOXIB17852-52-74-Hydrazino Benzene Sulphonomide HclANTI-INFLAMMATORY
7.2CELECOXIB720-94-54,4,4-Trifluoro 1-(4 Methylphenyl) Butane -1,3-DioneANTI-INFLAMMATORY
7.3CELECOXIB122-00-94-Methyl Aceto Phenone(KSM)ANTI-INFLAMMATORY

Send us your API (active pharma ingredients) inquiries to bdteam@sspharma.com

Close Menu